ResearcherUniversity Hospital Schleswig-HolsteinActive in the last 2 years
Hryhoriy V. Lapshyn
Matched on ORCID iD 0000-0002-0435-5189; OpenAlex author ID A5044441193. Sources: OpenAlex.
Their work
- Papers
- 14 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 35
2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 14
- Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? Co-author DOI 10.3390/cancers18152423↗
- An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from the German Cancer Registry Group. Co-author DOI 10.1016/j.ejso.2025.109693↗
- The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A cross-validation study of two national re… Co-author DOI 10.1016/j.surg.2023.11.004↗
- Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucinous Neoplasm versus Primary Pancreatic D… Co-author DOI 10.3390/cancers16112016↗
- Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperative symptoms within the DGAV StuDoQ|Pancre… Last author DOI 10.1016/j.surg.2023.04.042↗
- [Incidence, Treatment and Survival in Pancreatic Cancer- Data of the Nationwide Oncological Quality Conference from a Surgical Perspective]. Co-author DOI 10.1055/a-1768-1012↗
- Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Cancer Database (NCDB) and the German Cance… Co-author DOI 10.3390/cancers14040868↗
- Radiological prediction of portal vein infiltration in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2020.11.015↗
- Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenterico-Portal Vein During Pancreatoduodenect… Co-author DOI 10.21873/anticanres.15329↗
- Alignment of stroma fibers, microvessel density and immune cell populations determine overall survival in pancreatic cancer-An analysis of stromal morphology. Co-author DOI 10.1371/journal.pone.0234568↗
- Systematic Analysis of Accuracy in Predicting Complete Oncological Resection in Pancreatic Cancer Patients-Proposal of a New Simplified Borderline Resectabilit… Co-author DOI 10.3390/cancers12040882↗
- The impact of preoperative biliary stenting in pancreatic cancer: A case-matched study from the German nationwide pancreatic surgery registry (DGAV StuDoQ|Panc… Co-author DOI 10.1016/j.pan.2019.09.007↗
- Kidney Transplantation after Extended Multivisceral Resection for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1155/2018/3757382↗
- Prognostic factors after pancreatoduodenectomy with en bloc portal venous resection for pancreatic cancer. Co-author DOI 10.1007/s00423-015-1363-2↗
Closest collaborators
The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tobias Keck · 14 shared papers, 2016–2026 · strength 1.84
- Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
- Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
- Paper Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperativ… DOI 10.1016/j.surg.2023.04.042↗
- Louisa Bolm · 14 shared papers, 2016–2026 · strength 1.84
- Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
- Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
- Paper Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperativ… DOI 10.1016/j.surg.2023.04.042↗
- Ulrich Friedrich Wellner · 14 shared papers, 2016–2026 · strength 1.84
- Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
- Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
- Paper Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperativ… DOI 10.1016/j.surg.2023.04.042↗
- Kim C. Honselmann · 11 shared papers, 2020–2026 · strength 1.62
- Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
- Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
- Paper Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperativ… DOI 10.1016/j.surg.2023.04.042↗
- Rüdiger Braun · 9 shared papers, 2021–2026 · strength 1.41
- Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
- Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
- Paper Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperativ… DOI 10.1016/j.surg.2023.04.042↗
- Steffen Deichmann · 9 shared papers, 2020–2026 · strength 1.39
- Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
- Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
- Paper Recent onset diabetes is associated with better survival in pancreatic ductal adenocarcinoma-An analysis of preoperativ… DOI 10.1016/j.surg.2023.04.042↗
- Thaer S. A. Abdalla · 4 shared papers, 2024–2026 · strength 0.75
- Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
- Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
- Paper The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A c… DOI 10.1016/j.surg.2023.11.004↗
- Ekaterina Petrova · 6 shared papers, 2019–2022 · strength 0.63
- Paper Radiological prediction of portal vein infiltration in patients with pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2020.11.015↗
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Paper Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenteri… DOI 10.21873/anticanres.15329↗
- Lennart von Fritsch · 3 shared papers, 2024–2026 · strength 0.58
- Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
- Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
- Paper Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucin… DOI 10.3390/cancers16112016↗
- Dirk Bausch · 5 shared papers, 2016–2021 · strength 0.47
- Paper Radiological prediction of portal vein infiltration in patients with pancreatic ductal adenocarcinoma. DOI 10.1016/j.pan.2020.11.015↗
- Paper Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenteri… DOI 10.21873/anticanres.15329↗
- Paper Systematic Analysis of Accuracy in Predicting Complete Oncological Resection in Pancreatic Cancer Patients-Proposal of … DOI 10.3390/cancers12040882↗
- Natalie Petruch · 3 shared papers, 2021–2024 · strength 0.40
- Paper The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A c… DOI 10.1016/j.surg.2023.11.004↗
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Paper Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenteri… DOI 10.21873/anticanres.15329↗
- Birte Kulemann · 2 shared papers, 2021–2022 · strength 0.25
- Paper [Incidence, Treatment and Survival in Pancreatic Cancer- Data of the Nationwide Oncological Quality Conference from a S… DOI 10.1055/a-1768-1012↗
- Paper Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenteri… DOI 10.21873/anticanres.15329↗
- Dirk Rades · 2 shared papers, 2021–2022 · strength 0.23
- Paper Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Can… DOI 10.3390/cancers14040868↗
- Paper Postoperative Outcomes of Tangential versus Segmental Resection and End-to-end Reconstruction of the Superior Mesenteri… DOI 10.21873/anticanres.15329↗
- Yogesh Kumar Vashist · 2 shared papers, 2018–2020 · strength 0.19
- Carlos F. Fernandez-del Castillo · 1 shared paper, 2024 · strength 0.17
- Maximiliano Servín-Rojas · 1 shared paper, 2024 · strength 0.17
- Motaz Qadan · 1 shared paper, 2024 · strength 0.17
- Keith D. Lillemoe · 1 shared paper, 2024 · strength 0.17
- Jens Höppner · 1 shared paper, 2022 · strength 0.14
- Carlos Fernández-del Castillo · 1 shared paper, 2022 · strength 0.11
- Taisuke Baba · 1 shared paper, 2022 · strength 0.11
- Alexander V. Kirichenko · 1 shared paper, 2022 · strength 0.11
- Hiroki Sato · 1 shared paper, 2022 · strength 0.11
- Rodney E. Wegner · 1 shared paper, 2022 · strength 0.11
- Jon Michael Harrison · 1 shared paper, 2022 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.